Dermatology · Troy, MI
NPI
1265422497
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
255 Kirts Blvd
Troy, MI, 48084
Phone (248) 244-8448
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.4M
41,744 services
Medicare patients, 2024
1,187
Average age 76
Drug cost, 2024
$1.3M
3,404 prescriptions
Company payments, 2025
$52K
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by George J Murakawa was code 17003 (destruction skin lesion), 11,429 times for 935 patients. In total George J Murakawa billed 41,744 services in 135 codes, and Medicare paid $2.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 11,429 | 935 | $5.26 | $60K |
| J3245 Injection, tildrakizumab, 1 mg | Office | 5,500 | 17 | $107.61 | $592K |
| J2357 Injection, omalizumab, 5 mg | Office | 5,040 | 11 | $29.90 | $151K |
| 99213 Office E&M - Established | Office | 1,756 | 887 | $68.20 | $120K |
| 17000 Destruction Skin Lesion | Office | 1,741 | 954 | $41.05 | $71K |
| 95044 Test - Miscellaneous | Office | 1,130 | 14 | $3.93 | $4,447 |
| 99214 Office E&M - Established | Office | 890 | 421 | $98.69 | $88K |
| 17110 Destruction Skin Lesion | Office | 720 | 471 | $80.12 | $58K |
| 96910 Skin | Office | 712 | 22 | $91.15 | $65K |
| 88305 Surgical Pathology Examination | Office | 619 | 353 | $54.69 | $34K |
| 11104 Skin Biopsy | Office | 501 | 383 | $87.44 | $44K |
| 17004 Destruction Skin Lesion | Office | 409 | 245 | $130.85 | $54K |
| 96372 Injection Administration | Office | 394 | 91 | $11.15 | $4,395 |
| 17311 Mohs Surgery | Office | 390 | 260 | $426.91 | $166K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 363 | 58 | $0.75 | $274 |
By year: 2022 $2.3M for 37,358 services; 2023 $2.4M for 40,024 services; 2024 $2.4M for 41,744 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 619 | 353 | $54.69 | $34K |
| 36415 Venipuncture Blood Collection | 92 | 48 | $7.99 | $735 |
| 88331 Surgical Pathology Examination | 76 | 61 | $82.61 | $6,278 |
| 88304 Surgical Pathology Examination | 34 | 32 | $35.21 | $1,197 |
Medicare prescription drug claims, 2024
In 2024, the drug George J Murakawa prescribed most often to Medicare patients was Triamcinolone Acetonide, with 519 prescriptions and refills. In total George J Murakawa wrote 3,404 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 519 | 600 | 322 | $7,915 |
| Cephalexin Generic | 412 | 412 | 313 | $1,894 |
| Mometasone Furoate Generic | 333 | 349 | 200 | $5,930 |
| Alclometasone Dipropionate Generic | 254 | 280 | 178 | $9,375 |
| Doxycycline Hyclate Generic | 245 | 327 | 133 | $5,394 |
| Mycophenolate Mofetil Generic | 153 | 251 | 34 | $14K |
| Clobetasol Propionate Generic | 105 | 126 | 61 | $2,597 |
| Dupixent Syringe Dupilumab | 94 | 94 | 14 | $365K |
| Econazole Nitrate Generic | 76 | 88 | 50 | $2,249 |
| Montelukast Sodium Generic | 73 | 127 | 32 | $706 |
| Tacrolimus Generic | 70 | 78 | 46 | $7,052 |
| Methotrexate Methotrexate Sodium | 63 | 99 | 14 | $1,951 |
| Acitretin Generic | 54 | 77 | 12 | $27K |
| Prednisone Generic | 53 | 75 | 20 | $374 |
| Azelaic Acid Generic | 49 | 56 | 29 | $4,845 |
Brand drugs: 244 claims; generic drugs: 3,160 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid George J Murakawa $52K ($50K in general payments such as food, travel and fees and $1,837 for research) from 25 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $16K.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 24 | $16K |
| Genzyme Corporation SNY | 25 | $15K |
| Galderma Laboratories, L.P. GALD.SW | 38 | $9,358 |
| Novartis Pharmaceuticals Corporation NVS | 18 | $3,158 |
| Regeneron Pharmaceuticals, Inc. REGN | 11 | $1,960 |
| ConvaTec Inc. CTEC.L | 11 | $1,714 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 19 | $861 |
| Kyowa Kirin, Inc. 4151.T | 14 | $493 |
| Kerecis Limited | 9 | $407 |
| Abbvie Inc. ABBV | 6 | $404 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.